key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
Published 1 year ago • 120 plays • Length 5:54Download video MP4
Download video MP3
Similar videos
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023
-
6:00
the adaura trial: 2023 updates - targeted therapies in lung cancer 2023
-
6:14
key points from the adaura trial: osimertinib
-
2:11
neoadjuvant osimertinib and surgically resectable egfr - targeted therapies in lung cancer 2023
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
5:12
adaura trial: tagrisso & resectable egfr - leading developments & current questions in lung cancer
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
5:30:11
full event mainstage 2023 targeted therapies in lung cancer patient forum on-demand
-
11:41
the adaura trial: flaws and results - leading developments & current questions in lung cancer
-
5:42
osimertinib and the flaura trial
-
6:26
the adaura trial: the effect on egfr treatment
-
16:41
asco lung cancer roundtable - trial updates in nsclc - adaura trial and post surgery egfr mutation
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
-
2:37
q&a: what are the platform options for sbrt? - targeted therapies in lung cancer 2023
-
4:02
egfr resisters: an advocacy group - targeted therapies in lung cancer 2023
-
1:09:58
breakout second stage 2023 targeted therapies in lung cancer forum on-demand
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum